ARCHIVES

Wall Street Analyst Who Sounded Alarm Over Prostate Cancer Drug Provenge In JNCI Settles With SEC Over Shorting Dendreon Stock

This article is from The Cancer Letter archive.

Vol. 39 No. 45 | December 17, 2013

Download PDF Visit The Full Archive

Related Articles

NCI Plans Contract To Study Cancer Research Manpower Needs; Epidemiologist State Their Case

October 7, 1977

In Brief: Rogers Indicates He May Let Training Grant Bill Die

March 29, 1974

Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival

October 25, 2013

Community Hospital Oncology Program RFP Deadline Moved Back to Sept. 5

June 22, 1979

In Brief: David Sundial Named Health Director Of Senate Labor & Human Resources Committee’s HHS Office

September 20, 1985

Ludwig Cancer Research Donates $540 Million to Six Centers

January 10, 2014